Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Thauvin-Robinet, C; Maingueneau, C; Robert, E; Elefant, E; Guy, H; Caillot, D; Casasnovas, RO; Douvier, S; Nivelon-Chevallier, A
   Exposure to hydroxyurea during pregnancy: a case series
   LEUKEMIA
   
   C. Thauvin-Robinet et al., "Exposure to hydroxyurea during pregnancy: a case series", LEUKEMIA, 15(8), 2001, pp. 1309-1311
2. Ysebaert, L; Carli, PM; Casasnovas, RO; Girodon, F; Caillot, D; Mugneret, F; Maynadie, M
   Minimally differentiated acute myeloid leukemia (AML-M0) with lymphoid presentation at relapse: a case report
   LEUKEMIA
   
   L. Ysebaert et al., "Minimally differentiated acute myeloid leukemia (AML-M0) with lymphoid presentation at relapse: a case report", LEUKEMIA, 15(10), 2001, pp. 1673-1674
3. Bene, MC; Bernier, M; Casasnovas, RO; Castoldi, G; Doekharan, D; van der Holt, B; Knapp, W; Lemez, P; Ludwig, WD; Matutes, E; Orfao, A; Schoch, C; Sperling, C; van't Veer, MB
   Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients
   BRITISH JOURNAL OF HAEMATOLOGY
   
   M.C. Bene et al., "Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients", BR J HAEM, 113(3), 2001, pp. 737-745
4. Solary, E; Mannone, L; Moreau, D; Caillot, D; Casasnovas, RO; Guy, H; Grandjean, M; Wolf, JE; Andre, F; Fenaux, P; Canal, P; Chauffert, B; Wotawa, A; Bayssas, M; Gennes, P
   Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes
   LEUKEMIA
   
   E. Solary et al., "Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes", LEUKEMIA, 14(12), 2000, pp. 2085-2094
5. Casasnovas, RO; Haioun, C; Dumontet, C; Gabarre, J; Richard, B; Lederlin, P; Caillot, D; Stamatoullas, A; Morel, P; Quesnel, B; Blay, JY; Bouabdallah, K; Gisselbrecht, C
   Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas
   HAEMATOLOGICA
   
   R.O. Casasnovas et al., "Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas", HAEMATOLOG, 85(5), 2000, pp. 502-507
6. CASASNOVAS RO; CAMPOS L; MUGNERET F; CHARRIN C; BENE MC; GARAND R; FAVRE M; SARTIAUX C; CHAUMAREL I; BERNIER M; FAURE G; SOLARY E
   IMMUNOPHENOTYPIC PATTERNS AND CYTOGENETIC ANOMALIES IN ACUTE NONLYMPHOBLASTIC LEUKEMIA SUBTYPES - A PROSPECTIVE-STUDY OF 432 PATIENTS
   Leukemia
   
   R.O. Casasnovas et al., "IMMUNOPHENOTYPIC PATTERNS AND CYTOGENETIC ANOMALIES IN ACUTE NONLYMPHOBLASTIC LEUKEMIA SUBTYPES - A PROSPECTIVE-STUDY OF 432 PATIENTS", Leukemia, 12(1), 1998, pp. 34-43
7. BENE MC; BERNIER M; CASASNOVAS RO; CASTOLDI G; KNAPP W; LANZA F; LUDWIG WD; MATUTES E; ORFAO A; SPERLING C; VANTVEER MB
   THE RELIABILITY AND SPECIFICITY OF C-KIT FOR THE DIAGNOSIS OF ACUTE MYELOID LEUKEMIAS AND UNDIFFERENTIATED LEUKEMIAS
   Blood
   
   M.C. Bene et al., "THE RELIABILITY AND SPECIFICITY OF C-KIT FOR THE DIAGNOSIS OF ACUTE MYELOID LEUKEMIAS AND UNDIFFERENTIATED LEUKEMIAS", Blood, 92(2), 1998, pp. 596-599
8. MAYNADIE M; CAMPOS L; MOSKOVTCHENKO P; SABIDO O; AHO S; LENORMAND B; CARLI PM; GUYOTAT D; BENE MC; FAURE G; CAPIOD JC; GARDAIS J; FEUILLARD J; RAPHAEL M; LACOMBE R; LECALVEZ G; LEGLISE MC; DENEYS V; MASSON AM; BERNIER M; MALET AM; SALAUN C; BOURIN P; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; CHRETIEN P; SOLARY E; CASASNOVAS RO; MAYNADIE M; MOSKOVTCHENKO P; FAVRE M; BENSA JC; JACOB MC; WALLEF G; SARIAUX C; TRIMOREAU F; PRALORAN V; CAMPOS L; SABIDO O; VASSELON C; BRUNET C; PONCELET P; GUITARD AM; TAIB J; LAVABREBERTRAND T; JUNG G; KANDEL G; GARAND R; PHILIP P; SUDAKA I; MONPOUX F; VANHAEKE D; PERROT JY; MARIE JP; VALENSI F; VERGE V; HOMBERG JC; SCHAISON G; BOUMSELL L; DOUAY L; SAMSON T; BRIZARD A; DALIPHARD S; DRENOU B; LEES O; LENORMAND B; POILANE B; FALKENRODT A; ALBERT A; KUHLEIN E; ESTIENNE MH; BREMOND JL; DEGENNE M; LEBARON F; REUMAUX G; DUTHILLEUL P; BENE MC; FAURE G; BORDIGONI P; WITZ F; KOLLOPSARDA MN; BAYLE C; ANTONINI J; BOUCHEIX C; CHARPENTIER A
   HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS
   Leukemia & lymphoma
   
   M. Maynadie et al., "HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS", Leukemia & lymphoma, 25(1-2), 1997, pp. 135-143
9. MAINGON P; DHOMBRES A; CAILLOT D; CASASNOVAS RO; HORIOT JC
   TOTAL-BODY IRRADIATION IN THE TREATMENT OF MYELOMA BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
   European journal of cancer
   
   P. Maingon et al., "TOTAL-BODY IRRADIATION IN THE TREATMENT OF MYELOMA BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)", European journal of cancer, 33, 1997, pp. 448-448
10. WENDUM D; SEBBAN C; GAULARD P; COIFFIER B; TILLY H; CAZALS D; BOEHN A; CASASNOVAS RO; BOUABDALLAH R; JAUBERT J; FERRANT A; DIEBOLD J; DEMASCAREL A; GISSELBRECHT C
    FOLLICULAR LARGE-CELL LYMPHOMA TREATED WITH INTENSIVE CHEMOTHERAPY - AN ANALYSIS OF 89 CASES INCLUDED IN THE LNH87 TRIAL AND COMPARISON WITH THE OUTCOME OF DIFFUSE LARGE B-CELL LYMPHOMA
    Journal of clinical oncology
    
    D. Wendum et al., "FOLLICULAR LARGE-CELL LYMPHOMA TREATED WITH INTENSIVE CHEMOTHERAPY - AN ANALYSIS OF 89 CASES INCLUDED IN THE LNH87 TRIAL AND COMPARISON WITH THE OUTCOME OF DIFFUSE LARGE B-CELL LYMPHOMA", Journal of clinical oncology, 15(4), 1997, pp. 1654-1663
11. REBIBOU JM; CAILLOT D; CASASNOVAS RO; TANTER Y; MAILLARD N; SOLARY E; RIFLE G; GUY H
    PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN A MULTIPLE-MYELOMA PATIENT WITH END-STAGE RENAL-FAILURE
    Bone marrow transplantation
    
    J.M. Rebibou et al., "PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN A MULTIPLE-MYELOMA PATIENT WITH END-STAGE RENAL-FAILURE", Bone marrow transplantation, 20(1), 1997, pp. 63-65
12. CASASNOVAS RO; CAMPOS L; MUGNERET F; SARTIAUX C; CHARRIN C; BERNIER M; FAVRE M; GARAND R; CHAUMAREL I; BENE MC; FAURE G; SOLARY E
    IMMUNOPHENOTYPIC FEATURES OF CYTOGENETICALLY DEFINED ACUTE MYELOBLASTIC-LEUKEMIA (AML) SUBTYPES - A PROSPECTIVE-STUDY OF 432 PATIENTS
    Blood
    
    R.O. Casasnovas et al., "IMMUNOPHENOTYPIC FEATURES OF CYTOGENETICALLY DEFINED ACUTE MYELOBLASTIC-LEUKEMIA (AML) SUBTYPES - A PROSPECTIVE-STUDY OF 432 PATIENTS", Blood, 88(10), 1996, pp. 2231-2231
13. VANHAEKE DR; BENE MC; GARAND R; FAURE GC; GARDAIS J; LEGLISE MC; LECALVEZ G; BERNIER M; MASSY M; GRIVEAU AM; BROUTARD P; LEBRUN C; BONHOMME J; CHASSAGNE B; DEMEOCQ F; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; CHRETIEN P; SOLARY E; CASASNOVAS RO; MAYNADIE M; BENSA JC; FAVRE M; JACOB MC; SARTIAUX C; HUART JL; DROUET M; PRALORAN V; TRIMOREAU F; CAMPOS L; LARESE A; PONCELET P; BESSONFAURE I; BRUNET C; LAVABREBERTRAND T; TAIB J; KANDEL G; JUNG G; HARROUSSEAU JL; PHILIP P; MONPOUX F; BAUDOUIN F; SUDAKA I; CALDANI C; VANHAEKE D; BERNARD A; VALENSI F; BOURIN P; ARBORIO M; SCHAISON G; BOUMSELL L; ADAM M; DOUAI L; BRIZARD A; DALIPHARD S; GENETET N; FAUCHET R; DRENOU B; LEES O; LENORMAND B; VANNIER JP; SABIDO O; GUYOTAT D; VASSELON C; FALKENRODT A; ALBERT A; BREMOND JL; GEORGET MT; KUHLEIN E; LEBARON F; DUTHILLEUL P; REUMAUX F; FAURE G; KOLOPPSARDA MN; BORDIGONI P; WITZ F; BAYLE C; ANTONINI J; CHARPENTIER A
    EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
    Leukemia & lymphoma
    
    D.R. Vanhaeke et al., "EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA", Leukemia & lymphoma, 20(1-2), 1995, pp. 137-142
14. DUVILLARD L; GUIGUET M; CASASNOVAS RO; CAILLOT D; MONNIERZELLER V; BERNARD A; GUY H; SOLARY E
    DIAGNOSTIC-VALUE OF SERUM IL-6 LEVEL IN MONOCLONAL GAMMOPATHIES
    British Journal of Haematology
    
    L. Duvillard et al., "DIAGNOSTIC-VALUE OF SERUM IL-6 LEVEL IN MONOCLONAL GAMMOPATHIES", British Journal of Haematology, 89(2), 1995, pp. 243-249
15. GARAND R; BENE MC; GARDAIS J; DUBOSCMARCHENAY N; LACOMBE F; LEGLISE MC; LECALVEZ G; BERNIER M; MASSY M; GRIVEAU AM; BROUTARD P; LEBRUN C; BONHOMME J; CHASSAGNE B; DEMEOCQ F; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; SOLARY E; CASASNOVAS RO; MAYNADIE M; BENSA JC; FAVRE M; JACOB MC; SARTIAUX C; HUART JL; DROUET M; PRALORAN V; TRIMOREAU F; CAMPOS L; LARESE A; PONCELET P; BESSONFAURE I; BRUNET C; LAVABREBERTRAND TL; TAIB J; KANDEL G; JUNG G; HARROUSSEAU JL; PHILIP P; MONPOUX F; BAUDOUIN F; SUDAKA I; CALDANI C; POMIER G; BERNARD A; REGUER M; SCHILL H; BOURIN P; ARBORIO M; SCHAISON G; BOUMSELL L; ADAM M; DOUAI L; VANHAECKE D; BRIZARD A; ROUALET JP; TABARY T; CHAUMAREL I; GENETET N; FAUCHET R; DRENOU B; LEES O; LENORMAND B; VANNIER JP; LEPETIT JC; ACQUART S; SABIDO O; GUYOTAT D; VASSELON C; FALKENRODT A; ALBERT A; BREMOND JL; GEORGET MT; ROUBINET F; KUHLEIN E; LEBARON F; DUTHILLEUL P; REUMAUX F; FAURE G; KOLOPPSARDA MN; BORDIGONI P; WITZ F; BAYLE C; ANTONINI J; CHARPENTIER A
    A NEW APPROACH OF ACUTE LYMPHOBLASTIC-LEUKEMIA IMMUNOPHENOTYPIC CLASSIFICATION - 1984-1994 THE GEIL EXPERIENCE
    Leukemia & lymphoma
    
    R. Garand et al., "A NEW APPROACH OF ACUTE LYMPHOBLASTIC-LEUKEMIA IMMUNOPHENOTYPIC CLASSIFICATION - 1984-1994 THE GEIL EXPERIENCE", Leukemia & lymphoma, 13, 1994, pp. 1-5
16. CASASNOVAS RO; SOLARY E; CAMPOS L; MAYNADIE M; FAVRE M; BREMEND JL; GARAND R; BENE MC; FAURE G
    PROGNOSTIC RELEVANCE OF SURFACE-MARKERS IN ADULT DE-NOVO ACUTE MYELOBLASTIC LEUKEMIAS - A PROSPECTIVE-STUDY OF THE GROUPE DETUDE IMMUNOLOGIQUE DES LEUCEMIES (GEIL)
    Leukemia & lymphoma
    
    R.O. Casasnovas et al., "PROGNOSTIC RELEVANCE OF SURFACE-MARKERS IN ADULT DE-NOVO ACUTE MYELOBLASTIC LEUKEMIAS - A PROSPECTIVE-STUDY OF THE GROUPE DETUDE IMMUNOLOGIQUE DES LEUCEMIES (GEIL)", Leukemia & lymphoma, 13, 1994, pp. 7-10
17. GENNE P; DUCHAMP O; CAILLOT D; CASASNOVAS RO; GUY H; SOLARY E; CHAUFFERT B
    CINCHONINE, A POWERFUL MDR REVERSING AGEN T
    Bulletin du cancer
    
    P. Genne et al., "CINCHONINE, A POWERFUL MDR REVERSING AGEN T", Bulletin du cancer, 81(11), 1994, pp. 936-937